Loading
A phase 3 trial of Fludarabine, Treosulfan and Thiotepa in Leukaemia, run by St. Anna Kinderkrebsforschung, with a status the registry has not verified recently.
ALL-SCT BFM International- HSCT in Children and Adolescents With ALL is a phase 3 interventional study registered as NCT01423500 by St. Anna Kinderkrebsforschung, with 405 participants planned, started 2007-01 and due to reach its primary completion in 2011-09. Interventions recorded: VP16, TBI, VP16, ATG, TBI, Fludarabine, OKT3, Treosulfan, Thiotepa, VP16, ATG, TBI. Conditions recorded: Lymphoblastic Leukemia, Acute, Childhood;.
Linked to the drug Treosulfan because the registry names it among its interventions and Leukaemia among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Treosulfan and the tag pipeline.
Shares Fludarabine and the tag pipeline.
Shares Fludarabine and the tag pipeline.
Shares Fludarabine and the tag pipeline.
Shares Leukaemia (all types) and the tag pipeline.
Shares Leukaemia (all types) and the tag pipeline.
Shares Fludarabine and the tag pipeline.
Shares Leukaemia (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/